Health & Personal Care
HIGH
FDA DRUG
Fresenius Kabi Famotidine Injection Recall Expands for Microbial Contamination in 2.2 Million Vials
Fresenius Kabi USA, LLC recalls 2,199,850 vials of Famotidine Injection, U.S. distribution nationwide plus Alaska, Hawaii and Puerto Rico after endotoxin testing concerns. The microbial contamination risk prompted an immediate stop-use order. Healthcare providers and patients should follow recall guidance and seek alternatives through their providers.
Famotidine
Microbial Contamination